CSPC Pharmaceutical Group Limited (CSPCY)

USD 3.05

(-2.71%)

Total Liabilities Summary of CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited's latest annual total liabilities in 2023 was 11.26 Billion CNY , up 11.22% from previous year.
CSPC Pharmaceutical Group Limited's latest quarterly total liabilities in 2023 FY was 11.26 Billion CNY , up 11.22% from previous quarter.
CSPC Pharmaceutical Group Limited reported annual total liabilities of 10.12 Billion CNY in 2022, up 27.99% from previous year.
CSPC Pharmaceutical Group Limited reported annual total liabilities of 7.91 Billion CNY in 2021, up 13.55% from previous year.
CSPC Pharmaceutical Group Limited reported quarterly total liabilities of - CNY for 2023 Q1, down -100.0% from previous quarter.
CSPC Pharmaceutical Group Limited reported quarterly total liabilities of 10.16 Billion CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of CSPC Pharmaceutical Group Limited (2023 - 2003)

Historical Annual Total Liabilities of CSPC Pharmaceutical Group Limited (2023 - 2003)

Year	Total Liabilities	Total Liabilities Growth
2023	11.26 Billion CNY	11.22%
2022	10.12 Billion CNY	27.99%
2021	7.91 Billion CNY	13.55%
2020	6.96 Billion CNY	2.48%
2019	6.8 Billion CNY	-11.36%
2018	7.67 Billion HKD	49.65%
2017	5.12 Billion HKD	25.32%
2016	4.09 Billion HKD	3.35%
2015	3.95 Billion HKD	13.81%
2014	3.47 Billion HKD	-3.31%
2013	3.59 Billion HKD	-35.58%
2012	5.58 Billion HKD	40.36%
2011	3.97 Billion HKD	21.48%
2010	3.27 Billion HKD	2.52%
2009	3.19 Billion HKD	9.27%
2008	2.92 Billion HKD	366.45%
2007	626.75 Million HKD	-76.17%
2006	2.62 Billion HKD	-12.41%
2005	3 Billion HKD	15.58%
2004	2.59 Billion HKD	97.78%
2003	1.31 Billion HKD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 FY	11.26 Billion CNY	11.22%
2023 Q1	- CNY	-100.0%
2023 Q2	10.16 Billion CNY	0.0%
2023 Q3	- CNY	-100.0%
2023 Q4	11.26 Billion CNY	0.0%
2022 Q2	9.42 Billion CNY	0.0%
2022 Q4	10.12 Billion CNY	0.0%
2022 FY	10.12 Billion CNY	27.99%
2021 Q4	7.91 Billion CNY	0.0%
2021 FY	7.91 Billion CNY	13.55%
2021 Q2	7.54 Billion CNY	0.0%
2020 FY	6.96 Billion CNY	2.48%
2020 Q2	8.46 Billion CNY	0.0%
2020 Q4	6.96 Billion CNY	0.0%
2019 Q2	6.8 Billion CNY	0.0%
2019 FY	6.8 Billion CNY	-11.36%
2019 Q4	6.8 Billion CNY	0.0%
2018 Q2	7.75 Billion HKD	0.0%
2018 FY	7.67 Billion HKD	49.65%
2018 Q4	7.67 Billion HKD	0.0%
2017 Q4	5.12 Billion HKD	0.0%
2017 Q2	4.83 Billion HKD	0.0%
2017 FY	5.12 Billion HKD	25.32%
2016 FY	4.09 Billion HKD	3.35%
2016 Q2	4.38 Billion HKD	0.0%
2016 Q4	4.09 Billion HKD	0.0%
2015 Q4	3.95 Billion HKD	0.0%
2015 Q2	4.24 Billion HKD	0.0%
2015 FY	3.95 Billion HKD	13.81%
2014 FY	3.47 Billion HKD	-3.31%
2014 Q4	3.47 Billion HKD	0.0%
2014 Q2	3.69 Billion HKD	0.0%
2013 Q2	4.55 Billion HKD	0.0%
2013 Q4	3.59 Billion HKD	0.0%
2013 FY	3.59 Billion HKD	-35.58%
2012 FY	5.58 Billion HKD	40.36%
2012 Q4	5.58 Billion HKD	0.0%
2012 Q2	3.69 Billion HKD	0.0%
2011 FY	3.97 Billion HKD	21.48%
2011 Q2	3.64 Billion HKD	0.0%
2011 Q4	3.97 Billion HKD	0.0%
2010 Q4	3.27 Billion HKD	0.0%
2010 FY	3.27 Billion HKD	2.52%
2010 Q2	3.29 Billion HKD	0.0%
2009 Q4	3.19 Billion HKD	0.0%
2009 FY	3.19 Billion HKD	9.27%
2008 FY	2.92 Billion HKD	366.45%
2007 FY	626.75 Million HKD	-76.17%
2006 FY	2.62 Billion HKD	-12.41%
2005 FY	3 Billion HKD	15.58%
2004 FY	2.59 Billion HKD	97.78%
2003 FY	1.31 Billion HKD	0.0%

Peer Total Liabilities Comparison of CSPC Pharmaceutical Group Limited

Name	Total Liabilities	Total Liabilities Difference
AstraZeneca PLC	61.86 Billion USD	81.793%
Bristol-Myers Squibb Company PFD CONV 2	65.67 Billion USD	82.848%
CSPC Pharmaceutical Group Limited	1.53 Billion USD	-631.527%
Clarus Therapeutics Holdings, Inc.	67.62 Million USD	-16556.303%
Novartis AG	53.19 Billion USD	78.825%
PT Kalbe Farma Tbk.	255.94 Million USD	-4301.085%